Ben Fisher

Two New Potent Neurotransmitter Release Enhancers, 10,10-Bis(4-Pyridinylmethyl)-9(10H)-Anthracenone and 10,10-Bis(2-Fluoro-4-Pyridinylmethyl)-9(10H)-Anthracenone: Comparison to Linopirdine

Robert Zaczek, Robert J. Chorvat, J Saye et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 130 citations

Life Sciences, Neuroscience, Pharmacology +17

Discovery and in Vivo Evaluation of (<i>S</i>)-<i>N</i>-(1-(7-Fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9<i>H</i>-purin-6-amine (AMG319) and Related PI3Kδ Inhibitors for Inflammation and Autoimmune Disease

Timothy D. Cushing, Xiaolin Hao, Youngsook Shin et al. · Journal of Medicinal Chemistry · 2014 · 86 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Inhibiting NF-κB-inducing kinase (NIK): Discovery, structure-based design, synthesis, structure–activity relationship, and co-crystal structures

Kexue Li, Lawrence R. McGee, Ben Fisher et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 71 citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +17

Discovery and optimization of a series of liver X receptor antagonists

Xian‐Yun Jiao, David J. Kopecky, Ben Fisher et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 20 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Discovery of a new binding mode for a series of liver X receptor agonists

David J. Kopecky, Xian Yun Jiao, Ben Fisher et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 11 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14